RLF AgTech Accelerates Sales Growth and Diversifies Seasonal Revenue Streams
RLF AgTech is advancing its commercial growth strategy by expanding its nutrition and biologicals portfolio and rebuilding its Australian sales function, achieving a six-fold increase in customer receipts since early 2026.
- Six-fold increase in Australian sales receipts since February 2026
- Three operating divisions aligned to complementary seasonal cycles
- Axioma Biologicals gaining traction with corporate growers
- Leadership hires bolster commercial and financial capabilities
- Pilot lead generation program identifies 65,500 hectares of opportunity
Sales Surge Highlights Commercial Turnaround
RLF AgTech (ASX:RLF) has reported a striking rebound in its Australian sales function, with customer receipts since February 2026 reaching approximately $690,000; a six-fold increase compared to the same period last year. This surge underscores the impact of rebuilding efforts led by a new National Sales Manager appointed earlier this year, combined with targeted market engagement initiatives aimed at growers, agronomists, and distribution partners.
Diversified Revenue Model Spanning Australia and Asia
The company’s growth strategy hinges on three operating divisions that capture revenue across different agricultural seasons and geographies. RLF Australia focuses on broadacre winter cropping with sales concentrated in the first half of the calendar year. LiquaForce targets Queensland’s summer cropping and sugarcane markets, peaking mid-year, while the China and Asia division aligns with the opposite six-month period. This seasonal diversification is designed to smooth revenue volatility and build resilience against market fluctuations.
Axioma Biologicals Gains Commercial Traction
RLF’s nutrition and biologicals portfolio, particularly the Axioma Biologicals range, continues to advance through a staged commercial rollout. Over three growing seasons, the product has moved from field trials to broad-scale adoption by a major Australian corporate grain grower, with positive yield responses noted especially in wheat paddocks. These results are helping to refine application protocols and encourage uptake among additional corporate growers, signalling growing market acceptance.
Strengthening Leadership to Support Growth
Recent appointments of Andrew Hunter as Chief Financial Officer and Jeremy Evans as General Manager of LiquaForce reflect RLF’s commitment to bolstering its commercial and operational capabilities. These hires come amid ongoing efforts to execute a broader commercial turnaround and expand the company’s footprint across its core agricultural markets.
Pilot Lead Generation Program Targets New Opportunities
RLF has initiated a pilot lead generation program aimed at identifying new commercial opportunities in Australian broadacre agriculture. Early results from a two-week trial indicate potential customer opportunities spanning approximately 65,500 hectares. The pilot is set to conclude by the end of July 2026, after which the company will evaluate the findings to decide on a wider rollout. This initiative complements the company’s broader strategy to deepen market penetration and diversify its revenue base.
Bottom Line?
RLF’s multi-pronged approach to diversifying seasonal revenue and strengthening sales execution positions it for more balanced growth, though the success of its pilot programs and broader adoption of biological products remain key near-term indicators.
Questions in the middle?
- Will the pilot lead generation program translate into sustained new customer acquisitions?
- How rapidly can Axioma Biologicals expand beyond current corporate grower adoption?
- What impact will leadership changes have on operational efficiency and market expansion?
